Horse News and Research

RSS
Rapid responders in novel behavior treatment for IBS maintain improvement at 3-month follow-up

Rapid responders in novel behavior treatment for IBS maintain improvement at 3-month follow-up

Green exercise decreases risk of mental illness, improves sense of well-being

Green exercise decreases risk of mental illness, improves sense of well-being

Research finding sheds more light on the workings of lateral PFC

Research finding sheds more light on the workings of lateral PFC

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

Transcend Services submits $78.25M bid for acquisition of Spheris

Transcend Services submits $78.25M bid for acquisition of Spheris

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

2010 Internal Medicine conference at Toronto Convention Center

2010 Internal Medicine conference at Toronto Convention Center

Independently-conducted studies confirm significant bioavailability of orally delivered insulin

Independently-conducted studies confirm significant bioavailability of orally delivered insulin

Saddle Up Safely campaign: Understanding how diseases of horse can affect humans

Saddle Up Safely campaign: Understanding how diseases of horse can affect humans

SUVmax in head and neck squamous cell carcinoma patients predict overall survival

SUVmax in head and neck squamous cell carcinoma patients predict overall survival

Researchers adopt new technique to inhibit cancer growth

Researchers adopt new technique to inhibit cancer growth

Access Pharmaceuticals initiates Cobalamin technology program for targeted delivery of siRNA therapies

Access Pharmaceuticals initiates Cobalamin technology program for targeted delivery of siRNA therapies

First Edition: February 4, 2010

First Edition: February 4, 2010

MedQuist to acquire Spheris' domestic business

MedQuist to acquire Spheris' domestic business

Florida surgeon receives '2009 Country Doctor of the Year' award

Florida surgeon receives '2009 Country Doctor of the Year' award

Newspaper editors join in call for greater transparency in health talks

Newspaper editors join in call for greater transparency in health talks

Access Pharmaceuticals provides update on its Cobalamin insulin development program

Access Pharmaceuticals provides update on its Cobalamin insulin development program

Dopamine replacement therapy causes brain dysfunction in patients with Parkinson disease, study says

Dopamine replacement therapy causes brain dysfunction in patients with Parkinson disease, study says

'Cadillac' tax deal in the works

'Cadillac' tax deal in the works

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.